2023 ABAI Continuous Assessment Program - Block Two
The ABAI Continuous Assessment Program serves the need of board certified allergist/immunologists by allowing them to demonstrate their ongoing competence in the field. The program requires allergy/immunology specialists to read and successfully answer three review questions on each of 10 peer reviewed articles in the field every six months, along with correctly answering 10 multiple choice question on core topic areas in the specialty.
Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of American College of Allergy, Asthma & Immunolgy and California Society of Allergy, Asthma & Immunology (CSAAI). The American College of Allergy, Asthma & Immunolgy is accredited by the ACCME to provide continuing medical education for physicians.
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 6 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Target Audience
Board certified allergist/immunologists
Learning Objectives
At the conclusion of this activity, participants should be able to:
1. Outline the major literature published in the specialty during the past 1224 months
2. Demonstrate mastery of core knowledge central to the practice of allergy/immunology
All relevant financial relationships with ineligible companies have been mitigated.
Len Bacharier, MD, Planner
Consultant: Avillion, DBV, Kinaset, OM Pharma; Speaker: AstraZeneca, GSK, Novartis, Sanofi, Regeneron; DSMB: DBV; Advisory Board: Regeneron
Theresa Bingemann, MD, Planner
Consultant: Aimmune, ALK; Researcher: Novartis; Speaker: Sanofi
Christina Ciaccio, MD, Planner
Consultant: ALK, AstraZeneca, DBV, Genentech, Novartis, Sanofi-Genzyme; Advisory Board: Siolta; Speaker: Aimmune
Jeffrey Demain, MD, Planner
Advisory Board: Cogent Biosciences, Octapharma, Sanofi-Regeneron; Speaker: Blueprint Medicine
Hal Hoffman, MD, Planner
Consultant: Novartis; Research: Takeda, Zomagen, AB2Bio, Genentech
Giselle Mosnaim, MD, Planner
Research: Genentech, Sanofi-Regeneron, GSK, Novartis, Teva; Consultant: Novartis
Princess Ogbogu, MD, Planner
Advisory Board: AstraZeneca, GSK, Sanofi; Research: AstraZeneca, GSK, Blueprint Medical
Wanda Phipatanakul, MD, Planner
Advisory Board: AstraZeneca, Genentech, GSK, Novartis, Sanofi-Regeneron, Teva; Research: Genentech, Novartis, Sanofi-Regeneron, ALK, Circassia, Lincoln Diagnostics, Monaghan, ThermoFisher
David Bernstein, MD, Test Writer
Research: ALK, Regeneron, AstraZeneca, Bellus, Cheisi, GSK, IQVIA, Leo, Sanofi, Teva, ARS; Consultant: Gerson Lehman, ARS, Alpha Insights
Speaker: ALK; Advisory Board: Regeneron, Aquestive
Jonathan Bernstein, MD, Test Writer
Consultant: Eli Lilly, Escient, Jasper Therapeutics, ONO Pharmaceuticals, TLL Pharma, ALK, Allakos, AstraZeneca, BioCryst, Biomarin, Blueprint Medicines, CSL Behring, Elsevier, Celldex Therapeutics, Allergy Therapeutics, Sanofi-Regeneron, Shire/Takeda, Ionis, Kalvista, Merck, Novartis, Genentech, Opinose, Pharming; Speaker: GSK; Research: Teva, AstraZeneca, Ionis, Amgen
Kanwaljit Brar, MD, Test Writer
Consultant: Incyte
Neema Izadi, MD, Test Writer
Researcher: Teva
Michael Land, MD, Test Writer
Researcher: Quest Diagnostics
Jay Lieberman, MD, Test Writer
Advisory Board: ALK, Abbvie, Genentech, Aquestive, Novartis; Researcher: Aimmune, Regeneron, Abbvie; Adjudication DBV: Abbvie
Lindsey Moore, MD, Test Writer
Speaker: Aimmune; Researcher: Kenota
Anil Nanda, MD, Reviewer, Test Writer
Speaker: Sanofi
Thanai Pongdee, MD, Test Writer
Advisory Board: Blueprint Medicines; Consultant: GSK; Researcher: GSK
Christopher Randolph, MD, Test Writer
Speaker: Amgen, AstraZeneca, Boehringer Ingelheim, Grifols, Pfizer, GSK, Regeneron-Sanofi Adventis
Jeffrey Stokes, MD, Test Writer
Researcher: Sanofi, Regeneron
Dana Wallace, MD, Test Writer
Consultant: Bryn Pharma; Advisory Board: Sanofi, Abbvie
Julie Wang, MD, Test Writer
DMC Member: ALK; Consultant: Jubilant HollisterSteir; Researcher: Aimmune, DBV, Regeneron
The following have no relevant financial relationships with ineligible companies to disclose:
Marianna Castells, MD, Planner
Karla Adams, MD, Reviewer, Test Writer
Jack Becker, MD, Test Writer
Matt Bell, MD, Test Writer
Scott Feldman, MD, Test Writer
Corinne Keet, MD, Test Writer
Mitchell Lester, MD, Test Writer
Aidan Long, MD, Test Writer
Cecelia Mikita, MD, Test Writer
Michael Nelson, MD, Test Writer
Pavadee Poowuttikul, MD, Test Writer
Rebecca Scherzer, MD, Test Writer
Available Credit
- 6.00 AMA PRA Category 1 Credit™
- 6.00 Attendance